Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Regional Analysis - by Product, Material, Application [In-Vitro Diagnostics and Research], and End User

The Middle East & Africa blood collection tubes for liquid biopsy market was valued at US$ 2.75 billion in 2023 and is expected to reach US$ 9.85 billion by 2031; it is estimated to register a CAGR of 17.3% from 2023 to 2031.

Technological Advancements in Liquid Biopsy Bolster Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market

Liquid biopsy has revolutionized the way cancer disease states are detected and monitored. Circulating tumor cell (CTC) tubes, intracellular RNA tubes, circulating cell-free DNA (ccfDNA) tubes, cell-free RNA (cfRNA) tubes, genomic DNA (gDNA) tubes, and more advanced blood collecting tubes are available for liquid biopsy. The ccfDNAs, cfRNAs, and extracellular vehicles (EVs, also known as exosomes) are widely used due to which they are gaining considerable attention in cancer diagnosis. Disease-specific exosome or cfRNA analyses require draw-time concentrations of these analytes preserved in collected samples. Major market players focus on introducing new technologically advanced products in the market.

In November 2023, Illumina, Inc., launched TruSight Oncology 500 ctDNA v2, a research assay that enables noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) from blood when tissue testing is not feasible; the assay is also performed to complement tissue-based testing. In February 2024, Delfi Diagnostics, in collaboration with Immunocore Holdings plc, launched a new cancer monitoring test to examine blood for broken pieces of tumor DNA to explore its use in the detection of multiple malignancies. The DELFI-TF assay delivers a genome-wide measure of the proportion of cfDNA that is derived from a tumor, and it is highly correlated with the mutant allele fraction that is used to evaluate treatment response and resistance to immunotherapies in patients suffering from advanced-stage cancer conditions.

Thus, technological advancements in liquid biopsies for the detection of cancer are expected to introduce new growth trends in the Middle East & Africa blood collection tubes for liquid biopsy market in the coming years.

Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market Overview

South Africa is experiencing significant developments in healthcare facilities and infrastructure due to increased healthcare expenditure by the government. The country is also expected to receive investments from global pharmaceutical and medical device manufacturers, which is expected to create lucrative opportunities for the healthcare infrastructure.

Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market Segmentation

The Middle East & Africa blood collection tubes for liquid biopsy market is categorized into product, material, application, end user, country.

By product, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, intracellular RNA Tubes, and others. The ccfDNA/cfDNA Tubes segment held the largest share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.

In terms of material, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into plastic and glass. The plastic segment held a larger share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.

By application, the Middle East & Africa blood collection tubes for liquid biopsy market is bifurcated into in-vitro diagnostics (IVD) and research. The in-vitro diagnostics (IVD) segment held a larger share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.

In terms of end user, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into genetic diagnostic labs, research and development centers, conventional diagnostic centers, and others. The genetic diagnostic labs segment held the largest share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.

Based on country, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa segment held the largest share of Middle East & Africa blood collection tubes for liquid biopsy market in 2023.

Biocept Inc; Exact Sciences Corp; F. Hoffmann-La Roche Ltd; Greiner Bio-One International GmbH; MagBio Genomics, Inc; Norgen Biotek Corp; QIAGEN NV; Streck Inc; and Zymo Research Corporation are some of the leading companies operating in the Middle East & Africa blood collection tubes for liquid biopsy market.

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa blood collection tubes for liquid biopsy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa blood collection tubes for liquid biopsy market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.